Portsmouth Hospitals NHS Trust
show navigation
content

Strontium-89 Therapy Information

Background/Information

89Strontium-chloride (89Sr) is used to relieve bone pain in prostate cancer patients. Areas of bone with metastases contain rapidly dividing cells in comparison to healthy bone and tissue. The 89Sr localises selectively within these areas of bone.

89Sr Procedure

It is administered as an injection and delivered to the site where it is needed. The treatment takes effect over a couple of weeks. Pain relief can last from three to six months, although patient responses do vary. You will be treated as an out-patient in Nuclear Medicine by the member of Nuclear Medicine Physics team

Related content

Last updated - 16 August 2019
Working together to drive excellence in care for our patients and communities

Contact

Queen Alexandra Hospital
Cosham, Portsmouth
PO6 3LY
Tel: 023 9228 6000

© Portsmouth Hospitals NHS Trust

This website is maintained by the PHT Web Team. If you have any questions about the website please get in touch